Mobile Bearing Knees Get FDA Panel Nod For Class II; J&J Sees Competition
This article was originally published in The Gray Sheet
Executive Summary
Unicompartmental mobile bearing knees should be reclassified as Class II with special controls despite a lack of clinical safety data addressing implant wear and fracture, according to FDA's Orthopaedic & Rehabilitation Devices Panel
You may also be interested in...
MHRA, Eucomed Agree Guidance Needed To Clarify Reclassification Process
Guidance on the degree of evidence required for medical device reclassification will prevent friction of the type that arose between industry and regulators during European implant policymaking, MHRA's Steve Owen suggested June 24
MHRA, Eucomed Agree Guidance Needed To Clarify Reclassification Process
Guidance on the degree of evidence required for medical device reclassification will prevent friction of the type that arose between industry and regulators during European implant policymaking, MHRA's Steve Owen suggested June 24
Biomet Shoots From The Hip With Ceramic Offering, Mobile Bearing Knees
Biomet will submit a 510(k) for a total mobile bearing version of its Vanguard knee implant, contingent on FDA downclassification, according to VP-Corporate Development & Communications Greg Sasso